Current Report No. 01/2017

The Board of Directors of NESTMEDIC SA (a joint-stock company hereinafter referred to as “Issuer”, “Company”) with its registered office in Wrocław announces that on June 12, 2017 the Supervisory Board issued a positive opinion on the motion of the Board of Directors referred to the Extraordinary General Meeting on taking necessary action to transfer the Issuer’s listings from NewConnect to the main market of the Warsaw Stock Exchange before June 12, 2018. The ultimate resolution on transferring the Issuer’s listings will be made at the Issuer’s Extraordinary General Meeting. Legal basis: § 5 (4.1) of Exibit 3 to the Alternative Trading System Rules – Current and Periodical Information in the Alternative Trading System on the NewConnect Market (text according to legal condition as of August 08, 2016